239 related articles for article (PubMed ID: 31279825)
1. GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.
Leo LM; Familusi B; Hoang M; Smith R; Lindenau K; Sporici KT; Brailoiu E; Abood ME; Brailoiu GC
Neuroscience; 2019 Aug; 414():88-98. PubMed ID: 31279825
[TBL] [Abstract][Full Text] [Related]
2. Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.
Brailoiu E; Barlow CL; Ramirez SH; Abood ME; Brailoiu GC
Neuroscience; 2018 May; 377():105-113. PubMed ID: 29522856
[TBL] [Abstract][Full Text] [Related]
3. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of modulation of brain microvascular endothelial cells function by thrombin.
Brailoiu E; Shipsky MM; Yan G; Abood ME; Brailoiu GC
Brain Res; 2017 Feb; 1657():167-175. PubMed ID: 27998795
[TBL] [Abstract][Full Text] [Related]
5. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
AlSuleimani YM; Hiley CR
Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells.
Altmann JB; Yan G; Meeks JF; Abood ME; Brailoiu E; Brailoiu GC
J Neurochem; 2015 Jun; 133(5):629-39. PubMed ID: 25703621
[TBL] [Abstract][Full Text] [Related]
7. GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na
Bondarenko AI; Montecucco F; Panasiuk O; Sagach V; Sidoryak N; Brandt KJ; Mach F
Vascul Pharmacol; 2017 Feb; 89():39-48. PubMed ID: 28064014
[TBL] [Abstract][Full Text] [Related]
8. Characterization of calcium signals provoked by lysophosphatidylinositol in human microvascular endothelial cells.
Al Suleimani YM; Hiley CR
Physiol Res; 2016; 65(1):53-62. PubMed ID: 26596318
[TBL] [Abstract][Full Text] [Related]
9. The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+ -activated large-conductance K+ channels in endothelial cells.
Bondarenko AI; Malli R; Graier WF
Pflugers Arch; 2011 Jan; 461(1):177-89. PubMed ID: 21072666
[TBL] [Abstract][Full Text] [Related]
10. The GPR55 agonist lysophosphatidylinositol directly activates intermediate-conductance Ca2+ -activated K+ channels.
Bondarenko AI; Malli R; Graier WF
Pflugers Arch; 2011 Aug; 462(2):245-55. PubMed ID: 21603896
[TBL] [Abstract][Full Text] [Related]
11. Blood-Brain Barrier Disruption Mediated by FFA1 Receptor-Evidence Using Miniscope.
Lindenau KL; Barr JL; Higgins CR; Sporici KT; Brailoiu E; Brailoiu GC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216375
[TBL] [Abstract][Full Text] [Related]
12. The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.
Deliu E; Sperow M; Console-Bram L; Carter RL; Tilley DG; Kalamarides DJ; Kirby LG; Brailoiu GC; Brailoiu E; Benamar K; Abood ME
Mol Pharmacol; 2015 Aug; 88(2):265-72. PubMed ID: 25972448
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.
Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T
J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the Blood-Brain Barrier by Sigma-1R Activation.
Brailoiu E; Barr JL; Wittorf HN; Inan S; Unterwald EM; Brailoiu GC
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791182
[TBL] [Abstract][Full Text] [Related]
15. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
Obara Y; Ueno S; Yanagihata Y; Nakahata N
PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
[TBL] [Abstract][Full Text] [Related]
17. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
[TBL] [Abstract][Full Text] [Related]
19. Adenosine receptors regulate gap junction coupling of the human cerebral microvascular endothelial cells hCMEC/D3 by Ca
Bader A; Bintig W; Begandt D; Klett A; Siller IG; Gregor C; Schaarschmidt F; Weksler B; Romero I; Couraud PO; Hell SW; Ngezahayo A
J Physiol; 2017 Apr; 595(8):2497-2517. PubMed ID: 28075020
[TBL] [Abstract][Full Text] [Related]
20. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
